BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8200908)

  • 1. Specific region of the c-myc promoter is responsive to electric and magnetic fields.
    Lin H; Goodman R; Shirley-Henderson A
    J Cell Biochem; 1994 Mar; 54(3):281-8. PubMed ID: 8200908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-specific modulation of RNA synthesis and degradation by extremely low frequency electromagnetic fields.
    Greene JJ; Pearson SL; Skowronski WJ; Nardone RM; Mullins JM; Krause D
    Cell Mol Biol (Noisy-le-grand); 1993 May; 39(3):261-8. PubMed ID: 7687499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
    Lutz W; Schwab M
    Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
    Lavenu A; Pournin S; Babinet C; Morello D
    Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in promoter utilization in human and mouse c-myc genes upon transformation induction in temperature-sensitive cell lines.
    Luo Y; Krause MO
    J Cell Physiol; 1994 Aug; 160(2):303-15. PubMed ID: 8040189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
    Mitchell KO; Ricci MS; Miyashita T; Dicker DT; Jin Z; Reed JC; El-Deiry WS
    Cancer Res; 2000 Nov; 60(22):6318-25. PubMed ID: 11103792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC mRNA abundance is unchanged in subcultures of HL60 cells exposed to power-line frequency magnetic fields.
    Owen RD
    Radiat Res; 1998 Jul; 150(1):23-30. PubMed ID: 9650598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myc-mediated transactivation of HSP70 expression following exposure to magnetic fields.
    Lin H; Head M; Blank M; Han L; Jin M; Goodman R
    J Cell Biochem; 1998 May; 69(2):181-8. PubMed ID: 9548565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cis-platin responsive sequences in the human c-myc promoter.
    Spandidos DA; Zoumpourlis V; Lang JC
    Anticancer Res; 1991; 11(3):1339-42. PubMed ID: 1888169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 50 Hz magnetic fields on C-myc transcript levels in nonsynchronized and synchronized human cells.
    Desjobert H; Hillion J; Adolphe M; Averlant G; Nafziger J
    Bioelectromagnetics; 1995; 16(5):277-83. PubMed ID: 8554627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-MYC repression of promoter activity through core promoter elements.
    Lucas JM; Wilkie NM; Lang JC
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1446-52. PubMed ID: 8352803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two regulatory domains are required for downregulation of c-myc transcription in differentiating U937 cells.
    Skerka C; Zipfel PF; Siebenlist U
    Oncogene; 1993 Aug; 8(8):2135-43. PubMed ID: 8336940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.
    Mazure NM; Chauvet C; Bois-Joyeux B; Bernard MA; Nacer-Chérif H; Danan JL
    Cancer Res; 2002 Feb; 62(4):1158-65. PubMed ID: 11861398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
    Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
    J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased DNA synthesis in INIT/10T1/2 cells after exposure to a 60 Hz magnetic field: a magnetic-field or a thermal effect?
    Zhao YL; Johnson PG; Jahreis GP; Hui SW
    Radiat Res; 1999 Feb; 151(2):201-8. PubMed ID: 9952305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
    Himelstein BP; Lee EJ; Sato H; Seiki M; Muschel RJ
    Oncogene; 1997 Apr; 14(16):1995-8. PubMed ID: 9150367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.